LightChain Capital
Saint Louis, Michiganlightchain-capital.com
Overview
LightChain Capital is a venture capital firm and family office that invests primarily in early-stage life sciences and software companies, with a focus on advancing treatments for multiple myeloma and related cancers.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Wugen | Jul 2026 | Series C Extension | Co-investor |
| Allotera Therapeutics | Jul 2026 | Series C Extension | Co-investor |
| AI Proteins | Nov 2025 | Series A | Co-investor |
| Predicta Biosciences | Oct 2025 | Series A | Co-investor |
| Wugen | Aug 2025 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
